Beers M H, Storrie M, Lee G
UCLA Center for Health Sciences.
Ann Intern Med. 1990 Jan 1;112(1):61-4. doi: 10.7326/0003-4819-112-1-61.
To determine how often emergency department physicians prescribe medications that can adversely interact with other medications that their patients are already taking, which patients are at highest risk for potential adverse reactions, and which medications most frequently lead to adverse interactions.
Survey of elderly persons and other adults seeking care at an emergency department.
Four-hundred twenty-four randomly selected adults seeking care at a university-affiliated hospital emergency department.
We evaluated 424 randomly selected visits to a hospital emergency department made by 186 persons over age 65 and 238 younger adults; all of the subjects were discharged without hospital admission. Forty-seven percent of visits led to added medication, and in 10% of the visits in which at least one medication was added, a new medication added a potential adverse interaction. The interactions were determined by a computer program, were reviewed using explicit criteria, and were excluded if of uncertain or trivial clinical significance, rare, or not established for that specific drug. The number of medications used at presentation was the best predictor of whether a potential interaction would be introduced.
In the emergency departments studied, a medication history was recorded on every patient and was available to physicians, but physicians did not routinely screen for potential drug interactions. Further safeguards are needed to protect patients from receiving medications that could produce adverse interactions.
确定急诊科医生开具的药物与患者正在服用的其他药物发生不良相互作用的频率,哪些患者发生潜在不良反应的风险最高,以及哪些药物最常导致不良相互作用。
对在急诊科就诊的老年人和其他成年人进行调查。
从一所大学附属医院急诊科随机选取424名就诊的成年人。
我们评估了186名65岁以上的老年人和238名年轻人在医院急诊科的424次随机就诊情况;所有受试者均未住院即出院。47%的就诊导致增加了用药,在至少增加了一种药物的就诊中,10%的情况是新增药物产生了潜在的不良相互作用。这些相互作用由计算机程序确定,并使用明确的标准进行审查,如果临床意义不确定或微不足道、罕见或该特定药物未证实存在,则予以排除。就诊时使用的药物数量是是否会引入潜在相互作用的最佳预测指标。
在所研究的急诊科中,每位患者都记录了用药史且医生可以获取,但医生并未常规筛查潜在的药物相互作用。需要进一步采取保障措施,以保护患者避免接受可能产生不良相互作用的药物。